Today, Congresswoman Nikki Budzinski (IL-13) hosted a roundtable with independent pharmacists, pharmacy students and faculty ...
The "middlemen of medicine" have become obstacles to progress, often perpetuating inefficiencies and exacerbating healthcare's existing problems.
One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...
Analyst reactions to Donald Trump’s election victory were mixed Wednesday, with potential positives including an FTC that is ...
For example, the big-three PBMs are the dominant middlemen in drug transactions, and they’re each part of a company that also owns a top-10 insurer. So they could try to get better deals for their ...
It remains to be seen how well President Joe Biden’s Inflation Reduction Act will actually work in lowering prescription drug ...
Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company ...
Congresswoman Nikki Budzinski (IL-13) will host a roundtable discussion with independent pharmacists on Saturday, November 2, ...
10d
Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback